PDXs from a MYCN-amplified (MNA) NB (n = 6) were treated by cisplatin monotherapy, resulting either in stationary disease (n = 3) or progression (n = 3) under treatment (Fig. 3a and Supplementary Fig. 2a:I) as reported27. This evidence concerns the gene MYCN and neuroblastoma.